Role of antifibrotic drugs in the management of post-COVID-19 interstitial lung disease: A review of literature and report from an expert working group

Affiliations

• ¹ Department of Clinical Research, Pulmocare Research and Education Foundation, Pune, Maharashtra, India.
• ² Department of Respiratory Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
• ³ Department of Respiratory Medicine, C K Group of Hospitals, Kolkata, West Bengal, India.
• ⁴ Department of Respiratory Medicine, Sparsh Hospital, Ahmedabad, Gujarat, India.
• ⁵ Lung Care and Sleep Centre, Institute of Pulmonology, Medical Research and Development, Mumbai, Maharashtra, India.
• ⁶ Institute of Pulmocare and Research, Kolkata, West Bengal, India.
• ⁷ Department of Respiratory Medicine, Bhatia Hospital and Bombay Hospital, Mumbai, Maharashtra, India.
• ⁸ Department of Respiratory Medicine, Metro Institutes of Health Sciences, Noida, Uttar Pradesh, India.
• ⁹ Department of Respiratory Medicine, Christian Medical College, Vellore, Tamil Nadu, India.
• ¹⁰ Department of Respiratory Medicine, Narayana Hrudayalaya, Bengaluru, Karnataka, India.
• ¹¹ Department of Respiratory Medicine, Hinduja Hospitals, Mumbai, Maharashtra, India.